☰ Menu
Menu Menu

About us
- About Aspire
- Our Journey
Product & Innovation
- Research & Pipeline
- Portfolio
Investors
Partnerships
- Business Development
- International Sales
Social Responsibility
Media
Careers
Contact us
International Websites
- aspirepharma.de

1st brand launch: iAluRil

September 24, 2025

Related Articles

News

October 16, 2025

Medicines Optimisation Centricity – Reimagining Value in the Patient Pathway

Read Article

Press Releases

January 20, 2022

EPIMAX sees an award-winning start to 2022

Read Article

News

November 1, 2023

Medicines Optimisation Centricity – Getting It Right

Read Article

Home
About Aspire
Our Journey
Our values

Research & Pipeline
Our Portfolio
Our Investors
Business Development

International Sales
Social Responsibility
Careers at Aspire
Media

Contact

MAT-UK-COR-0055-1 | January 2026

Aspire Terms & Conditions of Sale

Morningside Terms & Conditions of Sale

Modern Slavery & Human Trafficking Policy

Terms & Conditions

© 2026 Aspire Pharma All Rights Reserved

Registered Office Address: 102 High Street, Godalming, Surrey, GU7 1DS

Aspire Pharma Limited is registered in England, Company number 06828501

Aspire Pharma incorporated in the UK The first products within the Pathway Portfolio of generic medicines launched...